Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/53715
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWodak, A.-
dc.contributor.authorAli, R.-
dc.contributor.authorSansom, L.-
dc.contributor.authorHenry, D.-
dc.date.issued2008-
dc.identifier.citationMedical Journal of Australia, 2008; 188(8):438-439-
dc.identifier.issn0025-729X-
dc.identifier.issn1326-5377-
dc.identifier.urihttp://hdl.handle.net/2440/53715-
dc.description.statementofresponsibilityAlex D. Wodak, Robert Ali, David Henry and Lloyd Sansom-
dc.language.isoen-
dc.publisherAustralasian Med Publ Co Ltd-
dc.source.urihttp://www.mja.com.au/public/issues/188_08_210408/wod10120_fm.html-
dc.subjectHumans-
dc.subjectOpioid-Related Disorders-
dc.subjectNaltrexone-
dc.subjectNarcotic Antagonists-
dc.subjectCapsules-
dc.subjectDrug Implants-
dc.subjectDrug Monitoring-
dc.subjectPatient Satisfaction-
dc.subjectAustralia-
dc.titleEnsuring the safety of new medications and devices: are naltrexone implants safe?-
dc.typeJournal article-
dc.identifier.doi10.5694/j.1326-5377.2008.tb01711.x-
pubs.publication-statusPublished-
dc.identifier.orcidAli, R. [0000-0003-2905-8153]-
Appears in Collections:Aurora harvest 5
Medical Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.